Oral viral infections are less virulent than injections. To compare the outcome of virus infection acquired orally versus injection, and the role of RNAi in both conditions, we infected wild-type w 1118 flies, and Ago-2 −/− and Dcr-2 −/− flies by two different routes: injecting the viruses directly into the thorax or through the gut by feeding the virus to the fly (oral infection). We used the positive-sense RNA viruses DCV, cricket paralysis virus (CrPV) and Flock House virus (FHV).
H ost-pathogen interactions prompt selective pressures that drive the evolution of survival strategies for both organisms 1, 2 . Of great consequence, the infection route taken by pathogens determines the adaptive strategies of the host by triggering differential immune responses 3, 4 . The outcome of such hostpathogen interactions is highly variable and ranges from deleterious infections with lethal or permanent damage to completely innocuous infections. For example, an acute viral infection is typically characterized by a rapid onset of disease, high viral replication rates and the production of large numbers of viral progeny. The infection is transient and is limited either by the death of the host or the active elimination (clearance) of the pathogen by the host immune system. On the other hand, a persistent infection results in the long-lasting production of viral progeny that is tolerated by the host 5 . Drosophila is a well-known model to study insect host-virus interactions, and Drosophila C virus (DCV) is its most studied natural pathogen, a positive-sense RNA virus belonging to the Dicistroviridae family. Most studies involving DCV have been performed via viral injections, while oral infection, which is probably the most frequent route of infection for this enterovirus, has largely been unexplored 6 . In general, DCV injection causes complete mortality within 3-13 days depending on the viral dose and the genetic background of the fly [7] [8] [9] [10] [11] . Although viral injection has successfully identified virulence factors of pathogens and host defence mechanisms, injecting the virus bypasses the natural protection barriers of the host.
Different methods of oral infection in Drosophila have been described, including exposing first-instar larvae to virus particles or feeding adult flies a mix of food and a pathogen solution 6 . Oral infections activate different responses, such as the Toll pathway 12 and the nutrient-responsive extracellular signal-regulated kinase (ERK) pathway 13, 14 . The small interfering RNA (siRNA) pathway is currently considered the major antiviral pathway of insects because it controls infection of a wide range of viruses, including RNA and DNA viru ses 8, 9, [15] [16] [17] [18] . The siRNA pathway is triggered by double-stranded RNA (dsRNA) molecules such as viral replicative intermediates. These dsRNA molecules are recognized and cleaved by Dicer-2 (Dcr-2) into 21-nucleotide viral siRNAs (vsiRNAs). Once produced, vsiRNAs guide the sequence-specific recognition and cleavage of viral RNAs by Argonaute 2 (Ago-2) 19 . In addition, RNA viruses produce viral-derived DNA (vDNA) molecules through the activity of endogenous retrotransposons, and this vDNA amplifies the RNAimediated antiviral immune response through the production of new vsiRNAs 20, 21 . In Drosophila, however, studies that have established the key role of the siRNA pathway have always relied on injections and not oral infections.
In this study, we performed oral viral infections in larvae and adult wild-type flies as well as in flies deficient for the siRNA pathway. The results uncover a mechanism of clearance and immune priming for RNA viruses in Drosophila, and widen the current view of antiviral immunity in insects.
to the infection as they succumb faster (Fig. 1a-c ). Viral loads were significantly higher in Ago-2 −/− flies than in wild-type flies at early but not at later times post infection ( Supplementary Fig. 1b) .
To investigate the role of the siRNA pathway in the antiviral response during an oral infection, Ago-2 −/− and Dcr-2 −/− flies were fed with DCV, CrPV, FHV or mock-infected, and survival of the mutant flies was compared to that of the w 1118 flies. To verify the amount of virus ingested and to rule out any effect of uncontrolled variation in feeding, we measured the amount of infectious viruses in individual flies after different oral exposure times (1 h, 8 h and 16 h) and compared it to the inoculum size of injections ( Supplementary Fig. 2 ). Following oral exposure, regardless of the exposure time, the infectious virus dose was significantly higher than that following injection of 50 TCID 50 units per fly. Moreover, the measured viral input after oral exposure was consistent between flies across experiments and across exposure times. This result confirms that oral exposure is a reliable route of experimental infection, allowing the dissection of antiviral immune responses under a more natural setting.
Less than 10% mortality was observed in w 1118 flies 15 days after oral infection with DCV, CrPV or FHV (Fig. 1d-f ), a result consistent with previous studies 12 , 23, 24 . In contrast, 20 Altogether, these results indicate that a viral infection initiated orally is less virulent than intrathoracic injection in both w 1118 and RNAi-deficient flies, despite exposure to a larger infectious dose. Of note, virulence encompasses all fitness costs of infection 25 and we only considered pathogen-induced mortality in the context of this study. Fig. 1d ), we monitored the viral loads during the course of the infection. We found that viral titres decreased in w 1118 flies, dropping at 15 d.p.i. to levels close to the detection threshold ( Fig. 2a,b ; Supplementary Fig. 3a-c ; and see Methods for details about calculations of mean-centred titres that account for experimental variation). In both Ago-2 −/− and Dcr-2 −/− flies, viral infection resulted in significantly increased mortality (Fig. 1d ) and higher viral loads overall (Fig. 2a,b (Fig. 2c) . These results suggest that during an oral infection with DCV, flies are capable of clearing the infection in an RNAi-independent manner. , Ago-2 −/− and Dcr-2 −/− adult flies were orally infected with a mix of sucrose and blue dye containing 5 × 10 8 TCID 50 units of DCV (d), CrPV (e) or FHV (f) and survival was measured daily. Four independent experiments with three biological replicates of n = 15 flies each per condition were analysed. Within each fly genotype, infection with any of the three viruses significantly increased mortality (P < 0.05). Error bars indicate s.e.m; n.s., not significant. Survival curves were compared via log-rank (Mantel-Cox) tests.
To rule out the possibility that the virus was not replicating at the early times of infection, we used a DCV suspension inactivated by ultraviolet irradiation (DCV UV) and we followed viral RNA levels by PCR with reverse transcription (RT-PCR) at 1 and 3 d.p.i. While viral RNA production at 1 d.p.i. in flies infected with the untreated virus was readily detected, flies infected with DCV UV showed a very weak PCR amplification product at 1 d.p.i., and viral RNA was no longer detectable by 3 d.p.i. (Supplementary Fig. 3d ). Furthermore, we deep-sequenced small RNAs from w 1118 flies orally infected with DCV at 3, 6 and 15 d.p.i. (Fig. 2d) . As mentioned above, vsiRNAs arise from viral dsRNA replication intermediates. A high amount of vsiRNAs was detected at 6 d.p.i., but this number dropped close to the background at 15 d.p.i. due to the lack of virus replication at this time point. Taken together, these results confirm that the following events occur during oral infections: (1) the virus is replicating, as shown by the abundant presence of vsiRNAs covering both positive and negative strands of the DCV genome; (2) the RNAi machinery is functional; and (3) the virus is eliminated despite evidence of active replication.
Next, we asked whether viral clearance was a common response to oral viral infections in Drosophila. We analysed viral titres at different time points during a oral CrPV infection. Consistent with the increased susceptibility to infection of Ago-2 −/− and Dcr-2 −/− flies (Fig. 1e) , an increase in viral replication was observed compared to w 1118 flies ( Fig. 3a,b ; Supplementary Fig. 4a-c ). An analysis of viral prevalence (Fig. 3c) showed again an elimination of the virus at later times (at 15 d.p.i., less than 5% for w 1118 , 15% for Ago-2 −/− and none for Dcr-2 −/− flies, were positive for CrPV on average). This result confirms that Drosophila is able to clear an oral viral infection even in the absence of the antiviral activity of the siRNA pathway.
Finally, we investigated the outcome of an oral infection with FHV, a virus that is not a natural Drosophila pathogen. Ago-2 −/− and Dcr-2 −/− flies were more susceptible to a oral FHV infection than w 1118 flies (Fig. 1f ) and displayed higher viral titres ( Fig. 3d,e ; Supplementary Fig. 4d-f) . However, we noted that at 15 d.p.i., over 85% of w 1118 flies, 100% of Ago-2 −/− flies and 95% of Dcr-2 −/− flies were still FHV-positive (Fig. 3f) . Thus, although an oral infection with the non-natural pathogen FHV is not cleared, w 1118 and RNAi mutant flies still control the burden of infection and survive against an orally delivered virus.
Infection initiated orally at the larval stage is only cleared at the adult stage. Since DCV is a natural pathogen of Drosophila and it is possible to initiate an infection by feeding the larvae with a virus suspension, we investigated viral clearance under these conditions. Drosophila eggs laid overnight in a regular rearing medium were soaked in a DCV stock (Fig. 4a) . When adult flies emerged, female flies were selected to monitor their survival and viral accumulation ( Fig. 4b-d flies showed an increased death rate, with ~50 and 20% mortality at 15 d.p.e., respectively. This increased susceptibility was also reflected in a higher viral accumulation over time (Fig. 4c,d ). However, viral titres of w 1118 and RNAi mutant flies decreased over time ( Fig. 4c,d ; Supplementary Fig. 5a -c), indicating that the virus is cleared at the adult stage in flies infected orally as larvae. We measured the viral prevalence and found that even though most flies were infected at 1 d.p.e., DCV prevalence decreased over time, reaching ~30% for w 1118 , 60% for Ago-2 −/− and 45% for Dcr-2 −/− flies at 15 d.p.e. (Fig. 4e ). Next, we used single-stranded quantitative PCR (ssqPCR) directed to the negative strand of the viral RNA to assess viral replication 26 .
Negative single-stranded viral RNA was detected at 3 d.p.e. and subsequently decreased until 15 d.p.e. for both w 1118 and Ago-2 −/− flies ( Supplementary Fig. 5d ), indicating that in flies derived from infected larvae, the virus is actively replicating at early time points after adult emergence. Indeed, we observed a 1,000-fold decrease in the number of vsiRNAs in w 1118 flies collected at 15 d.p.e. compared with those collected at 3 d.p.e. (Fig. 4f ). These findings indicate that a oral DCV infection initiated at the larval stage can be cleared at the adult stage.
We also found that the infection causes a significant decrease in larva-to-pupa survival in both w 1118 and Ago-2 −/− flies ( Supplementary Fig. 5e ) and that Ago-2 −/− pupae showed a higher viral accumulation than w 1118 pupae ( Supplementary Fig. 5f ). A decrease in the pupa-to-adult survival after DCV infection was also observed (Supplementary Fig. 5g ). DCV-infected w 1118 pupae showed vsiRNA molecules covering the entire viral genome, indicating that the virus is actively replicating and that the RNAi machinery is functional ( Supplementary Fig. 5h ). Ago-2
Ago-2
Ago-2 Altogether, these results show that wild-type and RNAi mutant flies clear a oral DCV infection initiated at the larval stage only when they reach the adult stage. The results also indicate that the RNAi-independent antiviral mechanisms allowing viral clearance are specific to the developmental stage.
Infection initiated orally at larval stage leaves a viral DNA form in the adult. Recently, we showed that adult flies infected with different RNA viruses produce vDNA molecules through the activity of endogenous retrotransposons 20, 21 . Since we observed that flies orally infected with DCV are capable of clearing the virus, we asked whether a vDNA would be produced during the infection. We extracted DNA and RNA from individual w 1118 adult flies from infected larvae at 3 and 15 d.p.e. (Fig. 5a,b) . At 3 d.p.e., when most of the flies are positive for DCV RNA, we detected DCV vDNA in 40% of them (Fig. 5a) . At 15 d.p.e., when most of the flies have already cleared the virus and are negative for DCV RNA, we detected vDNA in 70% of them, even in the absence or viral replication (Fig. 5b) . Therefore, an oral infection initiated at the larval stage leaves a trace under a DNA form in the adult, even after virus clearance.
vDNA serves as a template for the synthesis of new siRNA molecules that will boost the RNAi-mediated antiviral response. This amplification of the RNAi response can be mediated by 5′ -monophosphorylated (pRNA) or 5′ -triphosphorylated (tripRNA) siRNAs 20, 27 . To investigate whether the vDNA form present in adult flies infected as larvae was producing pRNAs and/or tripRNAs, we performed deep sequencing of whole adult flies at 15 d.p.e. These flies were negative for virus replication but positive for vDNA. The RNA fraction used to generate the library was treated with a 5′ -polyphosphatase enzyme to transform tripRNAs into pRNAs, and the results compared to an untreated library that excludes tripRNAs. We used Caenorhabditis elegans libraries as a positive control for the detection of tripRNAs. We observed an enrichment of 22-nucleotide-long small RNAs in treated C. elegans libraries (representing both pRNAs and tripRNAs) compared to untreated libraries (excluding tripRNAs), indicating the production of secondary tripRNAs (Fig. 5c) . In flies that cleared the virus and acquired a vDNA form, we could not detect a difference between treated and untreated libraries (Fig. 5d) . the premise that invertebrates that have previously encountered a pathogen appear to be protected upon secondary exposure to the same pathogen, a concept known as immune priming [28] [29] [30] [31] [32] . To explore whether larval exposure to DCV protects against subsequent reinfection, w 1118 adult flies derived from larvae orally infected with DCV were challenged either by oral infection or by injection with DCV and their survival monitored (Fig. 6a) . Following challenge by oral infection, DCV priming at the larval stage did not affect adult mortality (Fig. 6b) . We also measured a similar viral load in the DCV primed (DCV/DCV) flies and the control (mock infected/ DCV) flies (Supplementary Fig. 6a ). However, following challenge by injection, DCV priming at the larval stage protected adult flies (Fig. 6c) . This protection against future lethal infection is dependent on an intact RNAi pathway, as Ago-2 −/− and Dcr-2 −/− flies died at the same rate whether mock challenged or DCV challenged. Viral loads between mock-infected or DCV-challenged flies remained unchanged ( Supplementary Fig. 6b-d) . This increased survival despite unchanged viral loads suggests a change in tolerance, which is defined as the regression of health (survival) by pathogen load (viral titre) 33, 34 . Indeed, we observed a change in the slope of the tolerance curves between DCV primed and control flies (Fig. 6d) , suggesting that tolerance is the mechanism underlying immune priming. Finally, we tested whether the protection observed is virusspecific. Adult flies derived from larvae orally infected with DCV were challenged with CrPV or FHV. We did not observe protection against these reciprocal cross-infections ( Supplementary Fig. 6e-g ), indicating that the priming and the protection observed are virusand sequence-specific.
These results show that previous exposure to DCV by oral infection at the larval stage reduces the susceptibility to a lethal viral challenge later in life with the same virus, providing evidence of transstadial immune priming.
Discussion
The transmission route taken by pathogens to infect their hosts has a profound impact on the outcome of the infection 3, 4, 12, 35, 36 . In this work, we performed oral viral infections in larvae and adult Drosophila flies using different model RNA viruses. We found that delivering virus orally produces a less virulent infection than by injection. In addition, virus was undetectable in most of the orally infected flies after 15 days, showing that oral infections can be cleared despite active virus replication. Oral infections are probably the most usual route of infection in nature, and flies have presumably evolved specific mechanisms to control infections in their gut. In most oral DCV infections, the virus localizes to and is controlled locally at the gut level. However, previous studies have shown that in flies orally infected with DCV, the virus was detected in the intestinal visceral muscles 13 and in the fat body 12 . This indicates that the virus could be capable of breaching the midgut barrier, reaching the haemolymph, spreading systemically and eventually killing the fly. This would explain why some degree of virulence is observed when wild-type or RNAi mutant flies are orally infected with different RNA viruses.
Ago-2 −/− and Dcr-2 −/− flies were more susceptible after an oral challenge and displayed higher viral titres than wild-type flies, but unexpectedly, approximately 60% of infected flies were still alive 15 days after infection. The virus was still present in some flies, indicating that RNAi is not essential for reaching persistent infections initiated by oral infection. Furthermore, the virus was undetectable in some flies, showing that viral clearance is possible in the absence of a functional RNAi machinery. In addition, a previous study 37 discovered that Nora virus, a picorna-like virus that lacks cytopathic effects when injected into flies, can either give rise to persistent infections or be cleared independently of the RNAi pathway. These results challenge the current view that the siRNA pathway is essential during a viral infection and suggest that other antiviral 
Dcr-2 -/-DCV/DCV
Dcr-2 -/-mock infected/DCV n.s. mechanisms might be involved to control and eliminate the virus following oral infections. Conversely, we hypothesize that RNAi is essential for controlling systemic infections that are established once the virus breaches the gut barrier and colonizes other tissues. This may explain why injection of DCV, CrPV or FHV directly into the haemolymph is lethal. We also observed viral clearance in adult flies derived from DCVinfected larvae. In these flies, we also found evidence of viral replication preceding the clearance. Controversially, it was published that in adult flies derived from DCV-infected larvae, the virus is not actively replicating 26 . The authors of that study performed ssqPCR to detect negative-strand viral RNA (indicative of viral replication) but did not detect it. In our work, we detected negative-sense RNA using the same primers as that study 26 . We conjecture that the authors performed the measurement several days after the emergence of adult flies, when the virus was already cleared.
We found that adult flies derived from DCV-infected larvae produced a vDNA that remains even after viral clearance. It is tempting to speculate that the vDNA could protect flies from future reinfections. Studies of bees have shown that a percentage of the insect population carries a segment of the Israeli acute paralysis virus in their genome and that this subpopulation is resistant to the virus 38 . DCV vDNA could be actively involved in antiviral immunity, increasing resistance or tolerance to new viral infections in the same organism. In addition, this vDNA could be occasionally inherited and confer trans-generational protection, but additional studies are necessary to prove this hypothesis.
Finally, we found that adult flies derived from DCV-primed larvae display an increased tolerance to a subsequent lethal challenge with the same virus. This immune priming is RNAi-dependent and virus-specific. Interestingly, a previous study 39 showed that flies injected with a sublethal dose of DCV are not protected against a subsequent DCV lethal injection. This lack of protection indicates that the oral infection route is probably essential for effectively priming the immune response and that injection of virus cannot prime the system. These results, together with a study of Lepidoptera showing that these insects display protection against a DNA virus 40 , indicate that the phenomenon of immune priming in insects encompasses viral infections.
In conclusion, the use of different modes of infection (oral versus injection) revealed a substantial contrast in the antiviral immune response. The following findings were ascertained after oral viral exposure: (1) viral infections persist or are cleared at the adult stage; (2) RNAi is not essential for clearing viral infections or for reaching persistence; (3) infection leaves a trace in the host under a vDNA form even after clearance; (4) flies orally exposed to the virus as larvae are protected from lethality during reinfection by injection as adults; and (5) transstadial immune priming is RNAi-dependent, and virus-and sequence-specific. By revealing the fundamental difference between virus injection and oral infection, which is probably the most common route of infection in nature, our work opens a new avenue for the study of antiviral immune responses in insects and other invertebrates.
Methods
No statistical methods were used to predetermine sample sizes. Experiments were not randomized and the co-authors were not blinded to allocation during the experiments and assessments of the results. ;+ Fly stocks were on the same genetic background to that of w 1118 flies and harboured the sensitive allele of Pastrel 3L:7350895 (Thr). Flies were maintained on a standard cornmeal diet (Bloomington) at a constant temperature of 25 °C. All fly lines were cleaned of possible chronic infections (viruses and Wolbachia) as described previously 41 . In addition, fly stocks were analysed by RT-PCR with pairs of primers specific for CrPV, Drosophila A virus, Drosophila X virus, DCV, FHV and Nora virus.
Virus production and titration. DCV, CrPV and FHV stocks were prepared in w 1118 flies. Flies were injected intrathoracically with 500 TCID 50 per fly. When mortality was observed, flies were anaesthetized and squashed in PBS (3 flies per 100 μ l of PBS). The extract was frozen at − 80 °C, thawed and centrifuged for 15 min at 15,000 × g at 4 °C. The supernatant was recovered and filtered to eliminate bacteria, aliquoted and stored at − 80 °C. Stocks were titred in S2 cells and titres were measured using the end-point dilution method and expressed as TCID 50 . Titres for all virus stocks were approximately 5 × 10 9 TCID 50 per ml. To quantify the viral load in pupae and flies, individual pupae or flies were squashed in PBS (100 µ l) at the indicated time points and titred.
To inactivate DCV for UV irradiation, 250 μ l of virus stock was exposed to UV irradiation in a 24-well plate (area, 1 cm 2 ) on melting ice (to prevent heating effects and evaporation) for 15 min. The UV source (UVItec) emitted UV light at 312 nm. Samples were titrated after exposure to verify viral inactivation.
Viral infections.
Injection. Four to six days after emergence, female flies were injected intrathoracically using a nanoject (Nanoject II apparatus; Drummond Scientific) with 50 nl of a viral suspension in 10 mM Tris buffer, pH 7. An injection of the same volume of 10 mM Tris, pH 7 served as a mock-infected control. Infected flies were kept at 25 °C and transferred into fresh vials every 2 days.
Larva infection. Female and male (n = 25 each) were placed into a clean mediacontaining tube for 16 h. The next day, adult flies were removed and embryos were infected by adding virus stock solution (100 µ l) on top of them. The following day, embryos were re-infected with the same amount of virus. Developed pupae were carefully removed with a brush, washed three times with PBS and transferred to a new clean media-containing tube. Flies were collected after adult emergence for different tests.
Adult oral infection.
Four to six days after emergence, female flies were starved for 8 h in an empty tube. Then, flies were transferred to an empty tube containing a Whatman filter paper in the bottom that was embedded with a mix of virus stock in PBS (10% virus stock, 35% sucrose and 2% of blue dye). After 16 h, only the flies exhibiting a blue belly (corresponding to blue dye in the gut due to ingestion) were placed in clean media-containing tubes. Flies were transferred to clean mediacontaining tubes every 2 days during the course of the experiment.
Survival assays. Adult flies. Survival of infected flies (adults infected by injection or orally, and adults derived from infected larvae) was measured daily by counting the number of dead flies in each test tube. Fly mortality at day 1 was attributed to damage induced by the injection and/or manipulation procedure and were excluded from further analyses.
Larva and pupa survival. Male and female flies were transferred to egg-laying cages made of grape juice plates with yeast paste on top for 16 h. The next day, embryos were carefully collected and placed in regular media-containing tubes. Once pupae formed, the number of pupae was scored to calculate survival. Pupa-to-adult survival was calculated based on the number of adult flies that emerged from a known pupae number.
RNA extraction and library production. For each time point of infection analysed, total RNA was extracted from 15 flies or pupae. For each sample, 19-31-nucleotide small RNAs were purified from a 15% acrylamide/bisacrylamide (37.5:1), 7 M urea gel as described previously 42 . Purified small RNAs were used for library preparation using a NEBNext Multiplex Small RNA Library Prep for Illumina (New England BioLabs) with the 3′ adapter from Integrated DNA Technologies (linker 1) and in-house designed indexed primers. Libraries were diluted to 4 nM and sequenced using a NextSeq 500 High-Output Kit v.2 (Illumina) (75 cycles) on a NextSeq 500 sequencer (Illumina). Reads were analysed using inhouse Perl scripts.
5′-tripRNA sequencing. Total RNA (2 μ g) extracted with TRIzol was treated with 20 units of RNA 5′ -polyphosphatase enzyme (Epicentre) for 30 min at 37 °C. Treated samples were extracted with acid phenol:chloroform, pH 4.5 (Ambion) and precipitated with Glycoblue (15 μ g; ThermoFisher Scientific), 0.1 volume of 3 M sodium acetate and 2.5 volumes of ice-cold 100% ethanol overnight at − 80 °C. After centrifugation (30 min, 4 °C) and a 70% ethanol wash, RNA pellets were resuspended in water (20 μ l) and used to produce the small RNA libraries.
Bioinformatics analysis of small RNA libraries. The quality of fastq files was assessed using graphs generated by FastQC (www.bioinformatics.babraham.ac.uk/ projects/fastqc/). Using cutadapt (https://cutadapt.readthedocs.io/en/stable/), low-quality bases and adaptors were trimmed from each read. Only reads with acceptable quality (phred score 20) were retained. FastQC generated a second set of graphs on the fastq files created by cutadapt. Reads were mapped to genomes using bowtie1 (https://sourceforge.net/projects/bowtie-bio/files/bowtie/1.0.0/) with the − v 1 (one mismatch between the read and its target). bowtie1 generates results in sam format. All sam files were analysed using the samtools package (http:// samtools.sourceforge.net/) to produce bam-indexed files. To analyse these bam files, graphs were generated using custom R scripts (https://www.r-project.org/) and the Bioconductor (https://www.bioconductor.org/) Rsamtools and Shortreads libraries.
RNA extractions and RT-PCR.
Virus-containing samples were extracted with TRIzol (Invitrogen). Before RT-PCR analysis, samples were treated with DNase I (Roche). Complementary DNA molecules were produced with SuperScript II Reverse Transcriptase (Invitrogen) with random hexamer primers. PCR assays were performed using Green Taq DNA Polymerase (GenScript).
ssq-PCR. Total RNA was extracted from individual flies with TRIzol, then total RNA (1 μ g) was treated with DNase I (Roche). The cDNA was prepared by reverse transcription with SuperScript II Reverse Transcriptase (Invitrogen) using a DCV-tag primer (to selectively amplify the negative strand of DCV) or random hexamer primers (to target Rp49). Roche Universal SYBR Green Master Mix was used for ssq-PCR. Quantification was normalized to that of mRNA encoding the endogenous ribosomal protein Rp49. Data were calculated using the Δ Δ Cq method to compute relative gene expression values. DCV-R, DCV-tag and Tag primers (as previously described 26 ) and Rp49 103-F and Rp49 207-R primers (see sequences in the DNA oligonucleotides list provided in Supplementary Information) were used. A 7900HT Fast Real-Time PCR System (Applied Biosystems) was used with the following programme: 95 °C for 5 min, followed by 40 cycles of 95 °C for 15 s; 60 °C for 30 s, followed by a melt analysis to confirm that only the expected products were amplified.
DNA extraction for vDNA PCR analysis. DNA was simultaneously isolated with total RNA from individual flies according to the manufacturer's instructions of TRIzol. PCR analysis for the detection of DCV vDNA was performed using DreamTaq DNA polymerase with the primers indicated in each figure (see sequences in the DNA oligonucleotides list provided in Supplementary Information). PCR products were sequenced to confirm that the products being amplified corresponded to the targeted sequence.
Statistical analyses. Infection prevalence was analysed as a binary variable by logistic regression. Infectious viral titres were compared by analysis of variance (ANOVA) after log 10 transformation + 1. qPCR results were analysed by ANOVA after log 10 transformation of normalized values. Larva survival and pupa survival were analysed by a weighted full-factorial ANOVA of the percentage of pupation and percentage of adult emergence, respectively. Time point was considered an ordinal variable. Full-factorial models initially included interactions up to the second order. Because of missing combinations, the interaction between experiment and time point was omitted from the analysis of oral infection of adult flies by DCV, CrPV and FHV, and from the analysis of oral infection of larvae by DCV. For the same reason, the interaction between genotype and time point was omitted from the analysis of DCV-injected adult flies. Full models were subsequently reduced to minimal adequate models by backward elimination of non-significant terms in a stepwise fashion. Effects were considered statistically significant if P < 5%.
Because all the experiments were repeated multiple times, uncontrolled variation between experiments was accounted for in the statistical analyses. In addition, to visually correct for the experiment effect in the graphical representations, the raw data for viral titres and survival were adjusted for variation between experiments. Adjusted values were obtained using a statistical procedure that removes all the variation that can be explained by the experimental replicates and adjusts their means to be equal. This procedure consists of plotting the residuals from a one-way ANOVA as a function of the experiment. This procedure transforms the raw values into their deviation from the experimental mean, and the resulting adjusted values are centred around zero. The mathematical explanation is as follows. Let a be an observed value and log 10 (a) the log 10 -transformed value. When the observed values are estimated with the model that only includes the experimental effect, the estimate of log 10 (a) is log 10 (â), where â is the experimental average. Residuals are defined as the difference between the observed values and the estimated values and represent the variation unexplained by the model. They are calculated as log 10 (a) -log 10 (â), which can be written as log 10 (a/â). Therefore, residuals are the observed values scaled by their experimental average, expressed on a log 10 scale.
The comparison of survival curves was performed using a log-rank (Mantel-Cox) test.
All statistical analyses were performed in JMP v.10.0.2 (www.jmp.com) or Prism v.6.00 (www.graphpad.com).
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Sample size a) Injection experiments:
-Survival: two independent experiments with three biological replicates of 10 female flies each were analyzed (n=60 adult flies per condition).
-Viral load: two independent experiments with at least 8 flies per condition were analyzed.
Number of flies per virus (between brackets):
DCV. w1118: 1 dpi (15), 3 dpi (15), 6 dpi (12). Ago-2-/-: 1 dpi (15), 3 dpi (15).
CrPV. w1118: 1 dpi (15), 3 dpi (15). Ago-2-/-: 1 dpi (15), 3 dpi (15).
FHV. w1118: 1 dpi (15), 3 dpi (13), 6 dpi (14). Ago-2-/-: 1 dpi (15), 3 dpi (15), 6 dpi (8).
b) Oral infection experiments, different viral stocks were used for each experiment. As intra-experimental variability is higher during feeding than with injection, experiments were performed as follow: DCV. w1118: 1 dpi (83), 2 dpi (68), 3 dpi (83), 6 dpi (83), 9 dpi (73), 15 dpi (83) Ago-2-/-: 1 dpi (45), 2 dpi (30), 3 dpi (45), 6 dpi (35), 9 dpi (31), 15 dpi (37) Dcr-2-/-: 1 dpi (49), 2 dpi (36), 3 dpi (51), 6 dpi (51), 9 dpi (51), 15 dpi (51)
CrPV. w1118: 1 dpi (49), 2 dpi (34), 3 dpi (49), 6 dpi (49), 9 dpi (39), 15 dpi (49) Ago-2-/-: 1 dpi (52), 2 dpi (37), 3 dpi (52), 6 dpi (52), 9 dpi (42), 15 dpi (52) Dcr-2-/-: 1 dpi (30), 2 dpi (15), 3 dpi (30), 6 dpi (30), 9 dpi (30), 15 dpi (30) FHV. w1118: 1 dpi (30), 2 dpi (15), 3 dpi (30), 6 dpi (30), 9 dpi (30), 15 dpi (30) Ago-2-/-: 1 dpi (30), 2 dpi (15), 3 dpi (30), 6 dpi (30), 9 dpi (30), 15 dpi (30) Dcr-2-/-: 1 dpi (29), 2 dpi (15), 3 dpi (30), 6 dpi (30), 9 dpi (30), 15 dpi (28) 
